Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Roti

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Nature Reviews. Disease Primers|June 13, 2024
Acute lymphoblastic leukaemiaLuca Pagliaro, Sai-Juan Chen, Daniel Herranz, et al.
Leukemia|February 27, 2018
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangementRoberta La Starza, Monica Messina, Valentina Gianfelici, et al.
Cancers|June 2, 2021
Impact of the rs1024611 Polymorphism of <i>CCL2</i> on the Pathophysiology and Outcome of Primary MyelofibrosisElena Masselli, Cecilia Carubbi, Giulia Pozzi, et al.
Haematologica|February 14, 2007
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemiaRoberto Rosati, Roberta La Starza, Gianluca Barba, et al.
Oncotarget|November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF<sup>V600E</sup>Zeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testesNicola Giuliani, Cecilia Caramatti, Giovanni Roti, et al.
Cancer Cell|February 26, 2013
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancerGiovanni Roti, Anne Carlton, Kenneth N Ross, et al.
The Journal of Experimental Medicine|November 22, 2017
Leukemia-specific delivery of mutant NOTCH1 targeted therapyGiovanni Roti, Jun Qi, Samuel Kitara, et al.
Leukemia|March 30, 2019
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromesAnair Graciela Lema Fernandez, Barbara Crescenzi, Valentina Pierini, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Nature Reviews. Disease Primers|June 13, 2024
Acute lymphoblastic leukaemiaLuca Pagliaro, Sai-Juan Chen, Daniel Herranz, et al.
Leukemia|February 27, 2018
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangementRoberta La Starza, Monica Messina, Valentina Gianfelici, et al.
Cancers|June 2, 2021
Impact of the rs1024611 Polymorphism of <i>CCL2</i> on the Pathophysiology and Outcome of Primary MyelofibrosisElena Masselli, Cecilia Carubbi, Giulia Pozzi, et al.
Haematologica|February 14, 2007
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemiaRoberto Rosati, Roberta La Starza, Gianluca Barba, et al.
Oncotarget|November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF<sup>V600E</sup>Zeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testesNicola Giuliani, Cecilia Caramatti, Giovanni Roti, et al.
Cancer Cell|February 26, 2013
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancerGiovanni Roti, Anne Carlton, Kenneth N Ross, et al.
The Journal of Experimental Medicine|November 22, 2017
Leukemia-specific delivery of mutant NOTCH1 targeted therapyGiovanni Roti, Jun Qi, Samuel Kitara, et al.
Leukemia|March 30, 2019
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromesAnair Graciela Lema Fernandez, Barbara Crescenzi, Valentina Pierini, et al.
Pageof 8